Company

Artiva Biotherapeutics

As of the edition of 20 October 2026, Artiva Biotherapeutics runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Stopped1
Total2

Where its trials are

  • Cancer: 2 trials led
  • Immune system: 2 trials led
  • Skin and connective tissue: 2 trials led